BHC(SH:600721)2021-04-21 16:00Financial Performance - Net profit attributable to shareholders was CNY 1,071,993.40, representing a decline of 26.31% year-on-year[5] - Operating revenue for the period was CNY 47,264,446.74, an increase of 1.33% compared to the same period last year[5] - Basic earnings per share decreased by 19.44% to CNY 0.0029[5] - The company reported a net profit excluding non-recurring items of CNY 425,633.74, a significant improvement compared to a loss in the previous year[5] - The company reported a significant decrease in investment income for the current period, amounting to CNY 0.04 million, a reduction of 91.65% compared to the same period last year[15] - Operating profit for Q1 2021 was CNY 1,561,321.42, compared to CNY 1,024,934.61 in Q1 2020, indicating a growth of 52.2%[29] - The net profit for Q1 2021 was ¥614,431.60, a decrease of 30.7% from ¥885,802.02 in Q1 2020[33] - The operating profit for Q1 2021 was ¥841,495.74, down 38.2% from ¥1,362,642.26 in Q1 2020[32] - The total profit for Q1 2021 was ¥857,985.01, down 37.0% from ¥1,362,642.26 in Q1 2020[32] Cash Flow - The net cash flow from operating activities improved by 35.86%, reaching -CNY 13,620,328.17[5] - Net cash flow from operating activities for the current period was CNY -13.62 million, an improvement of CNY 7.61 million compared to the same period last year, mainly due to reduced cash payments to employees and lower tax payments[16] - The cash inflow from operating activities in Q1 2021 was ¥48,027,178.52, a decrease of 9.4% from ¥52,743,048.39 in Q1 2020[35] - The company's total cash inflow from operating activities was significantly impacted by increased payments to employees and other operational expenses, totaling 24,705,412.95 RMB in Q1 2021[38] - The total cash inflow from operating activities was 12,572,025.93 RMB, up from 4,524,293.84 RMB in the same period last year, reflecting a 178% increase[38] - The cash outflow for operating activities reached 27,802,445.08 RMB, compared to 5,116,316.98 RMB in Q1 2020, marking a 444% increase in cash outflows[38] Assets and Liabilities - Total assets at the end of the reporting period were CNY 960,827,824.81, a decrease of 1.42% compared to the end of the previous year[5] - Total liabilities as of March 31, 2021, were CNY 293.13 million, a decrease from CNY 308.24 million at the end of 2020[20] - Total assets as of March 31, 2021, amounted to CNY 714,984,479.82, slightly down from CNY 715,717,492.79 at the end of 2020[24] - Total liabilities as of March 31, 2021, were CNY 130,357,515.00, a decrease from CNY 131,704,959.57 at the end of 2020[25] - Shareholders' equity totaled CNY 584,626,964.82 as of March 31, 2021, compared to CNY 584,012,533.22 at the end of 2020, showing a slight increase[25] Shareholder Information - The total number of shareholders at the end of the reporting period was 9,702[11] - The largest shareholder, Xinjiang Hualing Industrial Trade Group Co., Ltd., held 21.20% of the shares[11] Expenses - Sales expenses for the current period were CNY 1.14 million, a decrease of CNY 0.19 million or 14.15% compared to the same period last year, primarily due to reduced sales business expenses[15] - R&D expenses for the current period were CNY 1.14 million, an increase compared to the same period last year due to expenses related to innovative drug research by a subsidiary[15] - Research and development expenses for Q1 2021 were CNY 1,139,542.38, indicating ongoing investment in innovation[29] Cash and Cash Equivalents - Cash and cash equivalents at the end of the period were CNY 41.79 million, a decrease of CNY 3.83 million or 8.40% from the beginning of the period, mainly due to reduced cash retention for operations[13] - Cash and cash equivalents decreased to CNY 4,388,814.55 from CNY 14,580,472.06 at the end of 2020, indicating a significant reduction in liquidity[23] - The total cash and cash equivalents at the end of Q1 2021 were 41,785,041.34 RMB, down from 51,123,162.82 RMB at the beginning of the quarter[37] - The company reported a cash and cash equivalents net decrease of 3,830,399.12 RMB in Q1 2021, compared to a decrease of 26,271,804.68 RMB in Q1 2020[37]